[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mckesson Corp (MCK)

Mckesson Corp (MCK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

McKesson's Q1 2027 Earnings: What to Expect

Irving, Texas-based McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. Valued at a market cap of $93.2 billion, the company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. 

PFE is expected to release its Q1 2027 earnings on Wednesday, Aug. 5, after the market closes.  Ahead of the event, analysts expect the company’s EPS to be $9.59 on a diluted basis, up 16.1% from $8.26 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in all of its last four quarters.  

Fundamentals

See More
  • Market Capitalization, $K 98,508,256
  • Shares Outstanding, K 117,078
  • Annual Sales, $ 403,430 M
  • Annual Income, $ 4,762 M
  • EBIT $ 6,212 M
  • EBITDA $ 6,941 M
  • 60-Month Beta 0.31
  • Price/Sales 0.24
  • Price/Cash Flow 18.46
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 35.56% (+1.68%)
  • Historical Volatility 29.84%
  • IV Percentile 99%
  • IV Rank 82.50%
  • IV High 39.00% on 05/06/26
  • IV Low 19.36% on 08/18/25
  • Expected Move (DTE 34) 61.63 (7.32%)
  • Put/Call Vol Ratio 0.16
  • Today's Volume 1,172
  • Volume Avg (30-Day) 629
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 18,756
  • Open Int (30-Day) 17,501
  • Expected Range 779.77 to 903.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $9.59
  • Number of Estimates 6
  • High Estimate $10.37
  • Low Estimate $9.25
  • Prior Year $8.26
  • Growth Rate Est. (year over year) +16.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
744.45 +13.02%
on 06/22/26
861.00 -2.28%
on 07/17/26
+61.59 (+7.90%)
since 06/17/26
3-Month
723.68 +16.27%
on 05/11/26
873.03 -3.62%
on 04/20/26
-24.99 (-2.88%)
since 04/17/26
52-Week
637.00 +32.09%
on 08/12/25
999.00 -15.78%
on 03/03/26
+131.11 (+18.46%)
since 07/17/25

Most Recent Stories

More News
McKesson's Q1 2027 Earnings: What to Expect

McKesson is expected to announce its second-quarter earnings next month, and Wall Street forecasts a double-digit rise in its profits.

XLV : 161.09 (-0.44%)
MCK : 841.39 (+0.01%)
$SPX : 7,457.69 (-1.01%)
2 Profitable Stocks Worth Investigating and 1 We Turn Down

2 Profitable Stocks Worth Investigating and 1 We Turn Down

MCK : 841.39 (+0.01%)
ACEL : 12.15 (-2.41%)
TILE : 33.06 (-2.74%)
McKesson (MCK) Stock Trades Down, Here Is Why

McKesson (MCK) Stock Trades Down, Here Is Why

MCK : 841.39 (+0.01%)
2 Large-Cap Stocks to Keep an Eye On and 1 We Ignore

2 Large-Cap Stocks to Keep an Eye On and 1 We Ignore

T : 21.81 (-0.77%)
MCK : 841.39 (+0.01%)
WAT : 368.98 (-2.44%)
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down

1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down

AMN : 35.00 (+2.28%)
MCK : 841.39 (+0.01%)
NVAX : 8.21 (-0.36%)
3 Reasons We Love McKesson (MCK)

3 Reasons We Love McKesson (MCK)

MCK : 841.39 (+0.01%)
McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference...

MCK : 841.39 (+0.01%)
Is Henry Schein Stock Underperforming the Nasdaq?

Henry Schein has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

$NASX : 25,520.24 (-1.40%)
HSIC : 87.82 (-0.50%)
MCK : 841.39 (+0.01%)
Is Cencora Stock Underperforming the Nasdaq?

Cencora has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

$NASX : 25,520.24 (-1.40%)
MCK : 841.39 (+0.01%)
COR : 307.90 (-0.03%)
3 Cash-Producing Stocks with Promising Prospects

3 Cash-Producing Stocks with Promising Prospects

MEDP : 537.73 (-0.04%)
MCK : 841.39 (+0.01%)
ALSN : 113.60 (-1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is...

See More

Key Turning Points

3rd Resistance Point 876.05
2nd Resistance Point 868.52
1st Resistance Point 854.96
Last Price 841.39
1st Support Level 833.87
2nd Support Level 826.34
3rd Support Level 812.78

See More

52-Week High 999.00
Fibonacci 61.8% 860.72
Last Price 841.39
Fibonacci 50% 818.00
Fibonacci 38.2% 775.28
52-Week Low 637.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.